Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)
Clinical trial NCT04147195 · TERMINATED
Trial details
- NCT number
- NCT04147195
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2022-01-06
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.